Vitreomacular traction
NICE Guidance
See drug specific guidance below
Ocriplasmin is a protease enzyme produced using recombinant DNA technology and it breaks down the proteins responsible for the adhesion in vitreomacular traction. It is for specialist use only and prescribed according to NICE criteria.